CRP and COVID-19: In a study of 25 patients with severe and/or life-threatening COVID-19, Salazar et al. stated that with CP administered at mean 6 days, there was a decrease in CRP and an increase in WBC on days 0, 7, and 14 days after the CP administration, and concluded that CP was a safe treatment option [31].